Back to Agenda
Closing Session
Session Chair(s)
Sara Torgal, MPharm
, European Medicines Agency (EMA), Netherlands
A must-attend review of the Conference Insights and Outcomes by the Conference Topic Leads, followed by closing remarks from the SVP and Managing Director of DIA EMEAI.
Speaker(s)
Ania Mitan
Senior Vice President & Managing Director, DIA EMEA and India, DIA, Switzerland
Take 5: Artificial Intelligence, Data Science & RWE
Álmath Spooner, PhD
Director of Regulatory Policy and Intelligence, AbbVie, Ireland
Take 5: Clinical Trials Development & Operations
Marianne Lunzer, DrMed
Assessor, Dept of Clinical Trials, Federal Office for Safety in Health Care, AGES, Austria
Take 5: CMC & Product Quality
Matt Popkin, PhD
Senior Director, CMC Excellence, Global Regulatory Affairs, GSK, United Kingdom
Take 5: International Collaboration & Regional Updates
Sara Torgal, MPharm
, European Medicines Agency (EMA), Netherlands
Take 5: Medical Devices & Combination Products
Tim Chesworth
Senior Director Regulatory Affairs , Novartis, United Kingdom
Take 5: Pharmacovigilance & Safety
James Whitehead, MBA, MSc
Former Senior Director Device & Digital Safety - AstraZeneca, Visiting Lecturer - Pharmacovigilance MSc Course, University of Hertfordshire, United Kingdom
Take 5: Professional Development
Claudia Ferreira
Scientific Programs Manager, DIA, Switzerland
Take 5: Regulatory Operations
Rodrigo Palacios, MBA
Senior Director, Regulatory Policy, F. Hoffman - La Roche Ltd., Switzerland
Take 5: Regulatory Strategy & EU Pharmaceutical Policy
Emma Du Four, MBA
Independent Regulatory and R&D Policy Professional, Independent, United Kingdom
Take 5: Value and Access
James Ryan, MSc
Director, Global HTA Policy , AstraZeneca (Global), UK, United Kingdom
Have an account?